ES2087199T3 - Vacunas contra virus de herpes equino y su fabricacion. - Google Patents

Vacunas contra virus de herpes equino y su fabricacion.

Info

Publication number
ES2087199T3
ES2087199T3 ES91117027T ES91117027T ES2087199T3 ES 2087199 T3 ES2087199 T3 ES 2087199T3 ES 91117027 T ES91117027 T ES 91117027T ES 91117027 T ES91117027 T ES 91117027T ES 2087199 T3 ES2087199 T3 ES 2087199T3
Authority
ES
Spain
Prior art keywords
manufacture
vaccines against
herpes viruses
equine herpes
against equine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91117027T
Other languages
English (en)
Other versions
ES2087199T5 (es
Inventor
Peter Prof Dr Dr Habil Thein
Walter Dr Strube
Ernst Bottcher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6416744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2087199(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2087199T3 publication Critical patent/ES2087199T3/es
Publication of ES2087199T5 publication Critical patent/ES2087199T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA SIGUIENTE INVENCION TRATA DE VACUNAS PARA LOS CABALLOS, CONTRA LAS INFECCIONES PRODUCIDAS POR VIRUS DE HERPES EQUINOS QUE SE BASAN EN GLICOPROTEINAS AISLADAS Y/O EN SUS COMPLEJOS CON LECTINAS DE CELULAS INFECTADAS DE EHV O DE VIRIONEN EHV EXTRACELULARES.
ES91117027T 1990-10-20 1991-10-07 Vacunas contra virus de herpes equino y su fabricacion. Expired - Lifetime ES2087199T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4033446A DE4033446A1 (de) 1990-10-20 1990-10-20 Impfstoffe gegen equine herpesviren und ihre herstellung

Publications (2)

Publication Number Publication Date
ES2087199T3 true ES2087199T3 (es) 1996-07-16
ES2087199T5 ES2087199T5 (es) 2002-03-16

Family

ID=6416744

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91117027T Expired - Lifetime ES2087199T5 (es) 1990-10-20 1991-10-07 Vacunas contra virus de herpes equino y su fabricacion.

Country Status (9)

Country Link
EP (1) EP0491125B2 (es)
JP (1) JPH05247099A (es)
AT (1) ATE136790T1 (es)
AU (1) AU649728B2 (es)
CA (1) CA2053829C (es)
DE (2) DE4033446A1 (es)
DK (1) DK0491125T4 (es)
ES (1) ES2087199T5 (es)
GR (1) GR3020044T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667104B2 (en) * 1992-06-01 1996-03-07 University Of Melbourne, The Equine herpesvirus glycoproteins
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
EP0978286A1 (en) * 1998-08-07 2000-02-09 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
ITMI20010571A1 (it) * 2001-03-19 2002-09-19 Grisotech S A Vaccini assorbibili per via trans-mucosale
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
WO1990001546A1 (en) * 1988-08-05 1990-02-22 Applied Biotechnology, Inc. Equine herpesvirus-1 vaccine

Also Published As

Publication number Publication date
GR3020044T3 (en) 1996-08-31
ES2087199T5 (es) 2002-03-16
EP0491125B1 (de) 1996-04-17
DK0491125T4 (da) 2002-01-28
JPH05247099A (ja) 1993-09-24
DK0491125T3 (da) 1996-08-05
CA2053829C (en) 2001-12-04
AU649728B2 (en) 1994-06-02
DE59107688D1 (de) 1996-05-23
ATE136790T1 (de) 1996-05-15
DE4033446A1 (de) 1992-04-23
EP0491125B2 (de) 2001-10-24
CA2053829A1 (en) 1992-04-21
EP0491125A1 (de) 1992-06-24
AU8599191A (en) 1992-04-30

Similar Documents

Publication Publication Date Title
MX9101540A (es) Polimeros de proantocianidina que tienen actividad antiviral y metodos para obtener los mismos
BR8705535A (pt) Polipeptideos derivados do gene de tegumento de virus de imunodeficiencia humana em celulas de insetos infectados por baculovirus
DE69017769D1 (de) Verbindungen.
DE69129207D1 (de) Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
MX9101810A (es) Vacuna contra virus de anemia de polio y diagnostico
ES2087199T3 (es) Vacunas contra virus de herpes equino y su fabricacion.
DK0553667T3 (da) Opløselig LDL-receptor, dens fremstilling og anvendelse
ATE199538T1 (de) Antivirusverbindungen
ES2078506T5 (es) Procedimiento para la decantacion de virus y para la determinacion de la cuota de decantacion de virus en soluciones.
ES546974A0 (es) Un procedimiento de eliminacion del virus lav.
ES2159815T3 (es) Compuestos antivirales.
DK178188A (da) Antivirusmiddel
OA09653A (en) Rubella peptides
IT8022385A0 (it) Agenti per la gelificazione di fluoroelastomeri e prodotti con essi ottenuti.
MX9102757A (es) Vacuna de virus de enfermedad de marek sin celulas.
ES507444A0 (es) Procedimiento para inactivar virus de la fiebre aftosa.
IT1194124B (it) Mezzo di protezione del bordo per cinghia articolata e cinghia articolata incorporante tale mezzo
ATE165620T1 (de) Impfstoffe auf basis geänderter boviner herpesviren typ 1
CA2141670A1 (en) Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
IT1178809B (it) Comosto di tetraetilammonio per l uso nel trattamento di malattie provocate da virus erpetici
ES2078380T3 (es) Oligofosfatos de accion antiviral.
FI930519A7 (fi) Peptiidejä HIV-viruksen aiheuttaman infektion torjumiseksi sekä menete lmä niiden käyttämiseksi
MX9307998A (es) Proteina de virus de varicela-zoster, derivados de la misma y vacuna que la contiene.
FI843163A7 (fi) Rokotteita ja koostumuksia hepatitis-B- virusinfektioita vastaan.
FI924278L (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0491125

Country of ref document: ES